Checking Up On Potential Coronavirus Treatment/Vaccine Plays
While there are currently no FDA-approved vaccines or therapeutics for it, today’s article notes that “A mix of legacy drugmakers and small startups have stepped…
While there are currently no FDA-approved vaccines or therapeutics for it, today’s article notes that “A mix of legacy drugmakers and small startups have stepped…
While investors dump stocks in sectors getting hit hardest by coronavirus fears, insiders at various companies in those sectors are buying up their own companies’…
For those investing for the long-term, the best thing to do in response to current market turmoil, driven by fears surrounding the novel coronavirus, may…
“The final week of February swallowed up all of Wall Street’s year-to-date gains – and then some. Given this level of volatility, one could argue…
“Fewer than half of analysts who cover the stock recommend buying it. Consider doing so just the same,” advises the author of today’s article in…
Dividend Aristocrats are great, but as the author of today’s article notes, “everyone already knows these firms are great. And as a result, their stocks…
What will end up being the best-performing stock of 2020? Nobody can say for sure. But looking at last year’s best-performing stocks may provide some…
If you’re sitting on shares with healthy profits and you want to protect your gains from a potential downturn, but you also want to maintain…
Growth stocks have been the better performers in recent years. Meanwhile, when it comes to value investing, some have declared value dead, while others believe…
Just five S&P 500 stocks trade for more than $1,000 a share. Among these five stocks are some well-known names (e.g. Amazon) and some lesser-known…